GeneOne Life Science Receives Approval for Phase I/IIa MERS-CoV Vaccine Trial in Korea

GeneOne Life Science Receives Approval of IND by the Korean Ministry of Food and Drug Safety (KMFDS) of MERS-CoV Plasmid DNA vaccine, GLS-5300, for a Phase I/IIa Clinical Trial in Korea SEOUL, KOREA (PRWEB) September 17, 2017¬†GeneOne Life Science, Inc. announces that it has received approval from the South Korean Ministry of Food and Drug […]

Special Message Regarding Hurricane Harvey

VGXI has reopened and we are getting back to normal operations. Our thoughts are with all those who have been affected by Hurricane Harvey, including our employees, their families, and all our neighbors in the area. For any who would like to contribute to the recovery effort, please consider a donation to one of the […]

Hurricane Harvey Update!

Update: VGXI will open for business on Thursday, August 31, 2017. To ensure the safety of our employees and their families, VGXI closed from Monday through Wednesday, August 28th – 30th, 2017. Please stay safe and check back on our website or facebook page for updates.

Meet VGXI at the 2017 ISV Congress

Heading to Paris in October? Meet with representatives from VGXI and learn more about our products and services! We also welcome requests for partnering meetings during the conference. Contact Us today to make arrangements.  2017 International Society of Vaccines Annual Congress October 5 Р7, 2017 Institute Pasteur Paris, France

VGXI Wins 2017 Vaccine Industry Excellence (ViE) Award for Best Contract Manufacturing Organization

VGXI announced that on April 10th, 2017 the corporation won the award for Best Production / Process Development at the 10th Annual ViE Awards Ceremony held at the 2017 World Vaccine Congress in Washington, D.C.